Data Foundry

Drug recalls 2014

NICOTINE POLACRILEX Lozenge — Class II drug recall D-550-2014

Terminated recall by Aidapak Services, LLC, reported 2014-01-22, distributed in AZ, CA, OR, WA. Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as ASPIRIN DR EC, Table

Recall numberD-550-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAidapak Services, LLC, Vancouver, WA, United States
Recall initiated2013-07-02
Classified2014-01-16
Reported by FDA2014-01-22
Terminated2014-02-07
DistributedAZ, CA, OR, WA
Quantity1,582 lozenges
Reason classeslabeling
Expiration dates2014-05-17, 2014-05-29, 2014-05-30, 2014-06-20, 2014-06-27

Product

NICOTINE POLACRILEX Lozenge, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 37205098769

Reason for recall

Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: AD52433_1, EXP: 5/17/2014; chlorproMAZINE HCl, Tablet, 100 mg, NDC 00832030300, Pedigree: AD70700_1, EXP: 5/29/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD73623_1, EXP: 5/30/2014; FOLIC ACID, Tablet, 1 mg, NDC 65162036110,

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-550-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.